{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/61958-2101#drug","name":"ODEFSEY","alternateName":"emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"61958-2101"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"NDA208351"},{"@type":"PropertyValue","propertyID":"UNII","value":"G70B4ETF4S|212WAX8KDD|FWF6Q91TZO"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"ea3b9ec8-e04a-412c-8b3f-e5cbc7e641d5"}],"activeIngredient":"EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, TENOFOVIR ALAFENAMIDE FUMARATE","administrationRoute":["ORAL"],"dosageForm":"TABLET","manufacturer":{"@type":"Organization","name":"Gilead Sciences, Inc."},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/NDA208351","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ea3b9ec8-e04a-412c-8b3f-e5cbc7e641d5","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=61958-2101"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-11T08:16:15.366Z"}}